Drug intelligence / Profile preview

68Ga-DOTA-NT

Development stage
Unknown
Lead developer
MedKoo Biosciences
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
Administration
Intravenous
01

Overview

68Ga-DOTA-NT is a radiopharmaceutical compound consisting of the neurotensin analog peptide DOTA-NT (DOTA-conjugated neurotensin) labeled with the positron-emitting radionuclide gallium-68. It is designed for use in positron emission tomography (PET) imaging to target and visualize tumors that overexpress the neurotensin receptor subtype 1 (NTSR1). The mechanism of action involves specific binding of the radiolabeled peptide to NTSR1 on tumor cells, enabling high-sensitivity detection and localization of NTSR1-positive malignancies, such as certain pancreatic adenocarcinomas. This agent has demonstrated higher PET detection rates for some cancers compared to standard tracers like 18F-FDG[2]. The compound is primarily used in research and investigational settings.

Other names
DOTA-NT-20.3DOTA-NT20.3DOTA-NT 20.3
02

Targets

NTR1 (Nitroreductase-1)

Beyond the preview

Go deeper on 68Ga-DOTA-NT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-DOTA-NT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call